Alzamend Neuro, Inc. (Nasdaq: ALZN) announced that an abstract reporting resting-state functional magnetic resonance imaging findings for its AL001 lithium ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA